Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Carbonate | HCID 10340 | — |
| Reactant | [5-(Cyclopropylcarbamoyl)-2-fluorophenyl]boronic acid | HCID 46738921 | — |
| Reactant | HCID 67959848 | HCID 67959848 | — |
| Catalyst | Bis(cyclopenta-1,4-dien-1-yl(diphenyl)phosphane);dichloropalladium;iron(2+) | HCID 178418228 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | HCID 67959840 | HCID 67959840 | — |
Reaction Steps
To a 5 mL conical microwave vial was added Pd(dppf)Cl2 (15.53 mg, 0.02 mmol), 1-(6-(5-bromo-1H-indazol-3-yl)pyrazin-2-yl)piperidin-4-amine dihydrochloride salt (Example 1) (71 mg, 0.19 mmol), and 5-(cyclopropylcarbamoyl)-2-fluorophenylboronic acid (46.7 mg, 0.21 mmol), capped, degassed and backfilled with argon (3×). Dioxane (1.9 mL) and 2N Na2CO3 aqueous solution (0.2 mL, 0.48 mmol) were added. The reaction mixture was stirred at 80° C. for 16 h. After cooling to RT, the reaction mixtures were filtered before concentrating under reduced pressure. The crude reaction mixture was purified by preparative HPLC using water with 0.1% NH4OH and ACN with 0.1% NH4OH (Column: Phenomenex Gemini-NX C18 110 A 5 μm, 21×100 mm) to afford the title compound. MS (ESI, pos. ion) m/z: 472 (M+1).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09090593B2 |
|---|
| Source dataset | uspto-grants-2015_07 |
|---|
| ORD ID | ord-93d1ea00b5174afd80650fa2d1351087 |
|---|
| Source note | uspto-grants-2015_07 |
|---|